Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$1.06 0.06 (5.36%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 147.47(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8871 - $4.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 17,438 35,533 57,514 116,582
Total Sell Value $26,639 $61,294 $139,194 $443,003
Total People Sold 3 5 5 9
Total Sell Transactions 3 9 12 23
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 939
  Page 12 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Walsh Jeffrey T. Chief Strategy Officer   •       –      –    2019-04-10 4 OE $24.47 $36,705 D/D 1,500 42,421     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-04-05 4 AS $156.33 $283,681 D/D (1,800) 32,092     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-04-05 4 OE $50.51 $83,226 D/D 1,300 33,892     -
   Davidson David Chief Medical Officer   •       –      –    2019-04-04 4 AS $159.47 $1,017,976 D/D (6,360) 31,616     -
   Davidson David Chief Medical Officer   •       –      –    2019-04-04 4 OE $5.50 $34,983 D/D 6,360 37,976     -
   Davidson David Chief Medical Officer   •       –      –    2019-03-13 4 AS $145.96 $454,005 D/D (3,101) 31,616     -
   Davidson David Chief Medical Officer   •       –      –    2019-03-13 4 OE $5.50 $17,057 D/D 3,101 34,717     -
   Walsh Jeffrey T. Chief Strategy Officer   •       –      –    2019-03-11 4 AS $139.80 $209,698 D/D (1,500) 40,921     -
   Walsh Jeffrey T. Chief Strategy Officer   •       –      –    2019-03-11 4 OE $24.47 $36,705 D/D 1,500 42,421     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-03-05 4 AS $146.02 $265,879 D/D (1,800) 32,592     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-03-05 4 OE $50.51 $83,226 D/D 1,300 34,392     -
   Davidson David Chief Medical Officer   •       –      –    2019-03-04 4 AS $155.07 $764,832 D/D (4,910) 31,616     -
   Davidson David Chief Medical Officer   •       –      –    2019-03-04 4 OE $50.51 $248,004 D/D 4,910 36,526     -
   Baird William D Iii Chief Financial Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 15,000 15,000     -
   Wentworth Kory James Principal Accounting Officer   •       –      –    2019-02-28 4 S $151.71 $7,737 D/D (51) 6,695     -
   Wentworth Kory James Principal Accounting Officer   •       –      –    2019-02-25 4 AS $150.00 $31,201 D/D (208) 6,746     -
   Cole Jason Chief Operating andLegal Offic   •       –      –    2019-02-25 4 AS $150.13 $938,698 D/D (6,248) 26,444     -
   Cole Jason Chief Operating andLegal Offic   •       –      –    2019-02-25 4 OE $22.53 $252,687 D/D 6,248 32,692     -
   Walsh Jeffrey T. Chief Financial andStrategy Of   •       –      –    2019-02-08 4 AS $130.99 $196,928 D/D (1,500) 40,921     -
   Walsh Jeffrey T. Chief Financial andStrategy Of   •       –      –    2019-02-08 4 OE $24.47 $36,705 D/D 1,500 42,421     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-02-05 4 AS $136.51 $248,383 D/D (1,800) 33,092     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-02-05 4 OE $50.51 $83,226 D/D 1,300 34,892     -
   Davidson David Chief Medical Officer   •       –      –    2019-02-04 4 AS $133.13 $659,417 D/D (4,910) 31,616     -
   Davidson David Chief Medical Officer   •       –      –    2019-02-04 4 OE $24.47 $155,432 D/D 4,910 36,526     -
   Leschly Nick President and CEO   •       •      –    2019-02-01 4 A $0.00 $0 D/D 25,000 218,203     -
  939 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us